Comparison of Study Drug and Entiviyo on the treatment of Colitis Research Question:
Is the study drug comparable or better at treating colitis than Entiviyo (Vedolizumab)
Basic Study Information
Purpose:Location: Strong Memorial Hospital
Study participation will last just under a year. Subjects will be randomized to receive
different dosages of either the study drug or Vedolizumab or placebo. Subjects are
required to visit the clinic 13 times for study related procedures. Infusions (IV
hookup) is the method for receiving the study drug.
Study Reference #: 20181346
Lead Researcher (Principal Investigator)
Lead Researcher: Lawrence Saubermann
Study Contact InformationStudy Coordinator: Lauren Ott
Phone: (585) 276-3042
Additional Study Details
Study sponsored by Genentech, Inc.
Number of Visits:
More than 10
Trial Not Found
The study you are looking for is not active at this time.
Return to Search